現有回應

• Lucien Lee標記此篇為：💬 含有個人意見

  理由

  輝瑞公司 CEO Albert Bourla 的確表示他們正在研發一種用於治療COVID-19症狀的口服藥物，「有可能會在」今年(2021)年底之前向公眾提供。該公司在新聞稿中表示，口服藥物可通過阻斷蛋白酶來起作用，蛋白酶是病毒能在體內複製的關鍵要素，該抑制劑藉由抑制蛋白酶，來阻
  
  閱讀更多

  不同意見

  - CNBC 報導 https://www.cnbc.com/2021/04/27/pfizer-a⋯-by-year-end-ceo-albert-bourla-says.html
  - WebMD 報導 https://www.webmd.com/lung/news/20210428⋯veloping-pill-to-treat-covid-19-symptoms

  Pfizer's new at-home pill to treat Covid could be available by end of the year, CEO hopes

  https://www.cnbc.com/2021/04/27/pfizer-at-home-covid-pill-could-be-available-by-year-end-ceo-albert-bourla-says.html

  The company in March began an early stage clinical trial testing a new antiviral therapy for Covid.

  https://www.webmd.com/lung/news/20210428/pfizer-developing-pill-to-treat-covid-19-symptoms

  Cannot get data from URL

增加新回應

• 撰寫回應
• 無相關回應
• 搜尋

你可能也會對這些類似文章有興趣